Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S V Vormfelde

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Archives of Internal Medicine|April 11, 2001
Safety of statins (hydroxymethyl glutaryl coenzyme a reductase inhibitors): different mechanisms of metabolism and drug transport may have clinical relevanceS V Vormfelde
The Medical Journal of Australia|December 11, 1999
Mortality associated with New South Wales methadone programsS V Vormfelde, W Poser
Pharmacopsychiatry|January 5, 2002
Death attributed to methadoneS V Vormfelde, W Poser
Archives of Internal Medicine|September 9, 2000
Hyperforin in extracts of St John's wort (Hypericum perforatum) for depressionS V Vormfelde, W Poser
The Pharmacogenomics Journal|September 30, 2010
The genetics of loop diuretic effectsS V Vormfelde, J Brockmöller
European Journal of Clinical Pharmacology|January 1, 1997
Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrateK H Schreeb, S Freudenthaler, S V Vormfelde, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?S V Vormfelde, A Bitsch, I Meineke, et al.
Clinical Pharmacology and Therapeutics|November 29, 2007
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamicsS V Vormfelde, M R Toliat, M Schirmer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2009
Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteersS V Vormfelde, J Brockmöller, S Bauer, et al.
The Pharmacogenomics Journal|September 14, 2006
Genetic variation at the CYP2C locus and its association with torsemide biotransformationS V Vormfelde, M Schirmer, M R Toliat, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Archives of Internal Medicine|April 11, 2001
Safety of statins (hydroxymethyl glutaryl coenzyme a reductase inhibitors): different mechanisms of metabolism and drug transport may have clinical relevanceS V Vormfelde
The Medical Journal of Australia|December 11, 1999
Mortality associated with New South Wales methadone programsS V Vormfelde, W Poser
Pharmacopsychiatry|January 5, 2002
Death attributed to methadoneS V Vormfelde, W Poser
Archives of Internal Medicine|September 9, 2000
Hyperforin in extracts of St John's wort (Hypericum perforatum) for depressionS V Vormfelde, W Poser
The Pharmacogenomics Journal|September 30, 2010
The genetics of loop diuretic effectsS V Vormfelde, J Brockmöller
European Journal of Clinical Pharmacology|January 1, 1997
Comparative bioavailability of two vitamin B1 preparations: benfotiamine and thiamine mononitrateK H Schreeb, S Freudenthaler, S V Vormfelde, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Non-response to maprotiline caused by ultra-rapid metabolism that is different from CYP2D6?S V Vormfelde, A Bitsch, I Meineke, et al.
Clinical Pharmacology and Therapeutics|November 29, 2007
The polymorphisms Asn130Asp and Val174Ala in OATP1B1 and the CYP2C9 allele *3 independently affect torsemide pharmacokinetics and pharmacodynamicsS V Vormfelde, M R Toliat, M Schirmer, et al.
Clinical Pharmacology and Therapeutics|April 17, 2009
Relative impact of genotype and enzyme induction on the metabolic capacity of CYP2C9 in healthy volunteersS V Vormfelde, J Brockmöller, S Bauer, et al.
The Pharmacogenomics Journal|September 14, 2006
Genetic variation at the CYP2C locus and its association with torsemide biotransformationS V Vormfelde, M Schirmer, M R Toliat, et al.
Pageof 2